DE3687097D1 - Therapeutisches mittel zur behandlung haematopoietischer krankheiten. - Google Patents

Therapeutisches mittel zur behandlung haematopoietischer krankheiten.

Info

Publication number
DE3687097D1
DE3687097D1 DE8686110996T DE3687097T DE3687097D1 DE 3687097 D1 DE3687097 D1 DE 3687097D1 DE 8686110996 T DE8686110996 T DE 8686110996T DE 3687097 T DE3687097 T DE 3687097T DE 3687097 D1 DE3687097 D1 DE 3687097D1
Authority
DE
Germany
Prior art keywords
treating
therapeutic agent
haematopoietic
diseases
haematopoietic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686110996T
Other languages
English (en)
Other versions
DE3687097T2 (de
Inventor
Tohru Masaoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Morinaga Milk Industry Co Ltd filed Critical Green Cross Corp Japan
Publication of DE3687097D1 publication Critical patent/DE3687097D1/de
Application granted granted Critical
Publication of DE3687097T2 publication Critical patent/DE3687097T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8686110996T 1985-08-09 1986-08-08 Therapeutisches mittel zur behandlung haematopoietischer krankheiten. Expired - Fee Related DE3687097T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60174325A JPH0753667B2 (ja) 1985-08-09 1985-08-09 骨髄移植療法補助剤

Publications (2)

Publication Number Publication Date
DE3687097D1 true DE3687097D1 (de) 1992-12-17
DE3687097T2 DE3687097T2 (de) 1993-04-22

Family

ID=15976665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686110996T Expired - Fee Related DE3687097T2 (de) 1985-08-09 1986-08-08 Therapeutisches mittel zur behandlung haematopoietischer krankheiten.

Country Status (6)

Country Link
US (1) US4845078A (de)
EP (1) EP0212501B1 (de)
JP (1) JPH0753667B2 (de)
AU (1) AU590783B2 (de)
CA (1) CA1283048C (de)
DE (1) DE3687097T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2577743B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
JP2577744B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
JPH0611705B2 (ja) * 1988-02-10 1994-02-16 新技術事業団 血小板減少症治療剤
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
JPH04502853A (ja) * 1988-10-07 1992-05-28 ユニバーシティ　オブ　サスカチェワン 原始細胞コロニー刺激因子およびリンパ造血始原細胞
US5256560A (en) * 1988-10-07 1993-10-26 University Of Saskatchewan Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US6852313B1 (en) 1989-10-16 2005-02-08 Amgen Inc. Method of stimulating growth of melanocyte cells by administering stem cell factor
US20040181044A1 (en) * 1989-10-16 2004-09-16 Zsebo Krisztina M. Method of stimulating growth of epithelial cells by administering stem cell factor
US7144731B2 (en) * 1989-10-16 2006-12-05 Amgen Inc. SCF antibody compositions and methods of using the same
AU6541090A (en) * 1989-10-16 1991-05-16 Amgen, Inc. Stem cell factor
CN100351267C (zh) * 2000-05-10 2007-11-28 南京大学 人尿抗瘤抗菌肽及其制备和应用
JP4859801B2 (ja) * 2007-09-28 2012-01-25 三洋電機株式会社 空気調和装置の室外ユニット

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
AU523077B2 (en) * 1978-03-20 1982-07-08 Green Cross Corporation, The Hgi glycoprotein
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4230697A (en) * 1978-07-03 1980-10-28 Morinaga Milk Industry Co. Ltd. Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
US4342828A (en) * 1979-07-20 1982-08-03 Morinaga Milk Industry Co., Ltd. Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
US4540574A (en) * 1979-11-22 1985-09-10 Cellena (Cell Engineering) A.G. Water soluble fraction capable of controlling the immune reactions of a host against allogenic cells or tissue, the pharmaceutical compositions containing said fraction and a process for preparing the latter
JPS59137417A (ja) * 1983-01-28 1984-08-07 Morinaga Milk Ind Co Ltd 人尿由来コロニ−形成刺激因子及びカリクレインの製造法

Also Published As

Publication number Publication date
EP0212501A3 (en) 1988-02-03
EP0212501B1 (de) 1992-11-11
AU6100386A (en) 1987-02-12
DE3687097T2 (de) 1993-04-22
JPH0753667B2 (ja) 1995-06-07
CA1283048C (en) 1991-04-16
EP0212501A2 (de) 1987-03-04
JPS6236326A (ja) 1987-02-17
US4845078A (en) 1989-07-04
AU590783B2 (en) 1989-11-16

Similar Documents

Publication Publication Date Title
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
FR2591116B1 (fr) Appareil de traitement par hyperthermie.
DE3673273D1 (de) Prophylaktische und therapeutische mittel fuer kreislaufkrankheiten.
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3588092D1 (de) Gerät zur Blutbehandlung
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3582894D1 (de) Hautbehandlungsmittel.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE3670310D1 (de) Elektrochemische behandlung von ligninen.
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE3680881D1 (de) Behandlung von hologrammen.
DE3485073D1 (de) Mittel zur bekaempfung von grundkrankheiten.
DE3777656D1 (de) Mittel zur behandlung von alopezien.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
NO880292L (no) Fremgangsmaate for behandling av humle.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
PT77020B (de) Mittel zur behandlung von wunden
DE3688625D1 (de) Therapeutische bandage.
LU84488A1 (de) Mittel zur behandlung von akne
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
DE3855561D1 (de) Mittel zur verhütung von zahnbelag und belagabhängigen krankheiten
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee